Your Shopping Cart Is Empty
| Report Code: A05900 | Oct 2021 | Pages: 231 | ||
| Tables: 113 | Charts: 43 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Veterinary Cro Market
Request Now !The global veterinary CRO market was valued at $577.20 million in 2020 and is projected to reach $1,175.72 million by 2030 registering a CAGR of 7.7% from 2021 to 2030. Contract research organizations (CROs) are companies that help assist in research & development and/or other services related to newer products for sponsor companies.
Sponsors frequently outsource their product development functions to independent service providers to augment their practice of a flexible cost structure and overcome the requirement to maintain redundant development proficiencies globally. Clinical, regulatory, and therapeutic expertise of CROs help improvise total cost of product development and market entry of a new product. Veterinary CROs are organizations that offer support to veterinary drug manufacturers in the form of services. For instance, clinical trials involve handling large number of animals, which require specially designed facilities; therefore, veterinary CROs manage clinical trials for companies, which are engaged in introduction of new veterinary medications.
Similarly, other services offered by veterinary CROs include regulatory support and market authorization process related to veterinary drugs. Furthermore, these organizations perform toxicology studies related to veterinary drugs to analyze safety and efficacy related to veterinary medicines. In addition, veterinary CROs conduct clinical trials for various indications in animals such as dermatology, gastrointestinal and others.
The Veterinary CRO market is driven due to an increase in companion animal ownership, an increase in animal health expenditure are the key factors anticipating the growth of market. In addition, increase in global prevalence of diseases among companion animals and surge in the R&D activities among veterinary medicine manufacturers act as key development factors that contribute toward growth of the market. In addition, surge in awareness related to animal healthcare across the globe is expected to offer remunerative opportunities for the market expansion during the forecast period. For instance, the Canadian Veterinary Medical Association (CVMA) organizes animal health week, which is a national public awareness campaign organized and hosted by veterinarians across Canada. The major aim of the awareness campaign is to promote animal health and responsible animal ownership. However, lack of standardization in veterinary CROs acts as a major restraint in the market. Conversely, surge in veterinary drug discovery is expected to offer lucrative opportunities during the forecast period.
The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. Due to the COVID-19 pandemic, governments across the globe announced country-wide lockdowns as well as social distancing measures to prevent collapse of the healthcare system. Governments have also issued limitations and bans on medical procedures and elective surgeries. These restrictions continue to impact the growth of various industries, and the immediate impact of the outbreak varies from industry to industry. The distribution, production, and supply chain have been affected, due to the implementation of lockdown across the globe.
The overall impact of COVID-19 remains positive for veterinary CRO market. As the COVID-19 phase has witnessed a significant rise in R&D practices in veterinary medicine. In addition, rise in number of COVID-19 infections in animals has alarmed various veterinary organizations across the world to assess specimens from domesticated as well as companion animals for COVID-19 virus. This has greatly facilitated use of these animals for experimental testing of SARS-CoV-2 veterinary vaccine, which serves as a valuable model for screening vaccines and antiviral drugs. For instance, Centers of Diseases Control and Prevention (CDC) recently reported that even animals are susceptible to the infection caused by SARS-CoV-2, several tests across the globe were undertaken to identify these animals and are currently used as animal models for research purposes.
Thus, helping researchers to determine possible treatments and predict antiviral and vaccine mechanisms for COVID-19 virus in affected animals. Therefore, rise in use of companion animals in COVID-19 veterinary clinical trials is predicted to impact positively on the growth of veterinary CRO market.
The veterinary CRO market is segmented into service type, animal type, indication, and region to provide a detailed assessment of the market. By service type, it is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, it is bifurcated into dogs & cats. By indication, it is classified into dermatology, gastrointestinal and others. By region it is bifurcated into North America, Europe, Asia-Pacific and LAMEA
By product, the clinical trial segment was the major revenue contributor, and is projected to grow significantly during the forecast period. Owing to increase in outsourcing of clinical trials, owing to its extensive nature due to which the entire process becomes lengthy and expensive. Thus, veterinary medicine manufacturing companies outsource clinical trials to veterinary CROs for managing lengthy procedures, which also involve handling of large number of animals in specialized facilities. Therefore, this factor considerably boosts the demand for clinical trial services offered by veterinary CRO.
By animal type, the dog segment was the major revenue contributor, and is projected to grow significantly, owing to surge in ownership of dogs as companion animals worldwide. Furthermore, surge in awareness related to dog health among their owners are the key factors driving the market growth during the forecast period.
By indication, the dermatology segment was the major revenue contributor, and is projected to grow significantly during the forecast period, owing to a rise in the prevalence of skin diseases such as abscesses, dermatoses and among others is the factor that drive the growth of market.
Major Key players operating in veterinary CRO market include Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd., VetPharm, Inc. and VETSPIN SRL.
Veterinary CRO Market Research Study Key Benefits
Veterinary CRO Market Report Highlights
| Aspects | Details |
|---|---|
| By SERVICE TYPE |
|
| By ANIMAL TYPE |
|
| By INDICATION |
|
| By Region |
|
| Key Market Players | LÖHLEIN & WOLF VET RESEARCH, CHARLES RIVER LABORATORIES, INC, ONCOVET CLINICAL RESEARCH, CLINVET, ONDAX SCIENTIFIC, VETSPIN SRL, VETERINARY RESEARCH MANAGEMENT (VRM) LTD, TRIVERITAS, KLIFOVET AG, VETPHARM, INC |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.1.1.Top impacting factors
3.1.2.Top investment pockets
3.2.Key forces shaping veterinary CRO industry/ market
3.2.1.Bargaining power of buyers
3.2.2.Bargaining power of suppliers
3.2.3.Threat of new entrants
3.2.4.Threat of substitutes
3.2.5.Intensity of competitive rivalry
3.3.Top player positioning, 2020
3.4.Top winning strategies
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Surge in ownership of companion animals
3.5.1.2.Rise in animal health expenditure
3.5.1.3.Increase in prevalence of diseases among companion animals
3.5.2.Restraint
3.5.2.1.Lack of standardization in veterinary CROs
3.5.3.Opportunity
3.5.3.1.Surge in awareness related to animal healthcare
3.5.4.Impact Analysis
3.6.COVID-19 Impact analysis on the market
CHAPTER 4:VETERINARY CRO MARKET, BY SERVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Clinical trials
4.2.1.Key market trends and growth opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Toxicology
4.3.1.Key market trends and growth opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Market authorization and regulatory support
4.4.1.Key market trends and growth opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Others
4.5.1.Key market trends and growth opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
CHAPTER 5:VETERINARY CRO MARKET, BY ANIMAL TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Dogs
5.2.1.Key market trends and growth opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Cats
5.3.1.Key market trends and growth opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
CHAPTER 6:VETERINARY CRO MARKET, BY INDICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Dermatology
6.2.1.Key market trends and growth opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Gastrointestinal
6.3.1.Key market trends and growth opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Others
6.4.1.Key market trends and growth opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:VETERINARY CRO MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.Market size and forecast, by country
7.2.3.North America market size and forecast, by service type
7.2.4.North America market size and forecast, by animal type
7.2.5.North America market size and forecast, by indication
7.2.5.1.U.S.
7.2.5.1.1.U.S. market size and forecast, by service type
7.2.5.1.2.U.S. market size and forecast, by animal type
7.2.5.1.3.U.S. market size and forecast, by indication
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by service type
7.2.5.2.2.Canada market size and forecast, by animal type
7.2.5.2.3.Canada market size and forecast, by indication
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by service type
7.2.5.3.2.Mexico market size and forecast, by animal type
7.2.5.3.3.Mexico market size and forecast, by indication
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Market size and forecast, by country
7.3.3.Europe market size and forecast, by service type
7.3.4.Europe market size and forecast, by animal type
7.3.5.Europe market size and forecast, by indication
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by service type
7.3.5.1.2.Germany market size and forecast, by animal type
7.3.5.1.3.Germany market size and forecast, by indication
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by service type
7.3.5.2.2.France market size and forecast, by animal type
7.3.5.2.3.France market size and forecast, by indication
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by service type
7.3.5.3.2.UK market size and forecast, by animal type
7.3.5.3.3.UK market size and forecast, by indication
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by service type
7.3.5.4.2.Italy market size and forecast, by animal type
7.3.5.4.3.Italy market size and forecast, by indication
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by service type
7.3.5.5.2.Spain market size and forecast, by animal type
7.3.5.5.3.Spain market size and forecast, by indication
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by service type
7.3.5.6.2.Rest of Europe market size and forecast, by animal type
7.3.5.6.3.Rest of Europe market size and forecast, by indication
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by service type
7.4.4.Asia-Pacific market size and forecast, by animal type
7.4.5.Asia-Pacific market size and forecast, by indication
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by service type
7.4.5.1.2.Japan market size and forecast, by animal type
7.4.5.1.3.Japan market size and forecast, by indication
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by service type
7.4.5.2.2.China market size and forecast, by animal type
7.4.5.2.3.China market size and forecast, by indication
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by service type
7.4.5.3.2.Australia market size and forecast, by animal type
7.4.5.3.3.Australia market size and forecast, by indication
7.4.5.4.Rest of Asia-Pacific
7.4.5.4.1.Rest of Asia-Pacific market size and forecast, by service type
7.4.5.4.2.Rest of Asia-Pacific market size and forecast, by animal type
7.4.5.4.3.Rest of Asia-Pacific market size and forecast, by indication
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA market size and forecast, by service type
7.5.4.LAMEA market size and forecast, by animal type
7.5.5.LAMEA market size and forecast, by indication
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by service type
7.5.5.1.2.Brazil market size and forecast, by animal type
7.5.5.1.3.Brazil market size and forecast, by indication
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia market size and forecast, by service type
7.5.5.2.2.Saudi Arabia market size and forecast, by animal type
7.5.5.2.3.Saudi Arabia market size and forecast, by indication
7.5.5.3.South Africa
7.5.5.3.1.South Africa market size and forecast, by service type
7.5.5.3.2.South Africa market size and forecast, by animal type
7.5.5.3.3.South Africa market size and forecast, by indication
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by service type
7.5.5.4.2.Rest of LAMEA market size and forecast, by animal type
7.5.5.4.3.Rest of LAMEA market size and forecast, by indication
CHAPTER 8:COMPANY PROFILES
8.1.CHARLES RIVER LABORATORIES, INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Service portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments
8.2.CLINVET
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Service portfolio
8.2.5.Key strategic moves and developments
8.3.KLIFOVET AG
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Service portfolio
8.3.5.Key strategic moves and developments
8.4.LÖHLEIN & WOLF VET RESEARCH
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Service portfolio
8.5.ONCOVET CLINICAL RESEARCH
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Service portfolio
8.6.ONDAX SCIENTIFIC
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Service portfolio
8.7.TRIVERITAS
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Service portfolio
8.7.5.Key strategic moves and developments
8.8.VETERINARY RESEARCH MANAGEMENT (VRM) LTD
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Service portfolio
8.9.VETPHARM, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Service portfolio
8.10.VETSPIN SRL
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Service portfolio
LIST OF TABLES
TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)
TABLE 02.POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2020
TABLE 03.PARASITE DISEASES & THEIR PREVALENCE IN U.S.,2020
TABLE 04.VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 05.VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY REGION, 2020-2030 ($MILLION)
TABLE 06.VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY REGION, 2020-2030 ($MILLION)
TABLE 07.VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY REGION 2020-2030 ($MILLION)
TABLE 08.VETERINARY CRO MARKET FOR OTHER SERVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 09.VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 10.VETERINARY CRO MARKET FOR DOGS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.VETERINARY CRO MARKET FOR CATS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 13.VETERINARY CRO MARKET FOR DERMATOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 14.VETERINARY CRO MARKET FOR GASTROINTESTINAL, BY REGION, 2020-2030 ($MILLION)
TABLE 15.VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY REGION 2020-2030 ($MILLION)
TABLE 16.VETERINARY CRO MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 21.U.S. VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 22.U.S. VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 23.U.S. VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 24.CANADA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 25.CANADA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 26.CANADA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 27.MEXICO VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 28.MEXICO VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 29.MEXICO VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 30.EUROPE VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 31.EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 32.EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 33.EUROPE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 34.GERMANY VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 35.GERMANY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 36.GERMANY VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 37.FRANCE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 38.FRANCE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 39.FRANCE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 40.UK VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 41.UK VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 42.UK VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 43.ITALY VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 44.ITALY VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 45.ITALY VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 46.SPAIN VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 47.SPAIN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 48.SPAIN VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 49.REST OF EUROPE VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 50.REST OF EUROPE VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 51.REST OF EUROPE VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 54.ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 55.ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 56.JAPAN VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 57.JAPAN VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 58.JAPAN VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 59.CHINA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 60.CHINA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 61.CHINA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 62.AUSTRALIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 63.AUSTRALIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 64.AUSTRALIA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 65.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 66.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 68.LAMEA VETERINARY CRO MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 69.LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 70.LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 71.LAMEA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 72.BRAZIL VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 73.BRAZIL VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 74.BRAZIL VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 75.SAUDI ARABIA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 76.SAUDI ARABIA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 77.SAUDI ARABIA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 78.SOUTH AFRICA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 79.SOUTH AFRICA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 80.SOUTH AFRICA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 81.REST OF LAMEA VETERINARY CRO MARKET, BY SERVICE TYPE, 2020-2030 ($MILLION)
TABLE 82.REST OF LAMEA VETERINARY CRO MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 83.REST OF LAMEA VETERINARY CRO MARKET, BY INDICATION, 2020-2030 ($MILLION)
TABLE 84.CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT
TABLE 85.CHARLES RIVER LABORATORIES, INC.: OPERATING SEGMENTS
TABLE 86.CHARLES RIVER LABORATORIES, INC. PLC: SERVICE PORTFOLIO
TABLE 87.CLINVET: COMPANY SNAPSHOT
TABLE 88.CLINVET INC.: OPERATING SEGMENTS
TABLE 89.CLINVET INC.: SERVICE PORTFOLIO
TABLE 90.KLIFOVET AG: COMPANY SNAPSHOT
TABLE 91.KLIFOVET AG: OPERATING SEGMENTS
TABLE 92.KLIFOVET AG: SERVICE PORTFOLIO:
TABLE 93.LÖHLEIN & WOLF VET RESEARCH: COMPANY SNAPSHOT
TABLE 94.LÖHLEIN & WOLF VET RESEARCH: OPERATING SEGMENTS
TABLE 95.LÖHLEIN & WOLF VET RESEARCH: SERVICE PORTFOLIO
TABLE 96.ONCOVET CLINICAL RESEARCH: COMPANY SNAPSHOT
TABLE 97.ONCOVET CLINICAL RESEARCH: OPERATING SEGMENTS
TABLE 98.ONCOVET CLINICAL RESEARCH: SERVICE PORTFOLIO
TABLE 99.ONDAX SCIENTIFIC: COMPANY SNAPSHOT
TABLE 100.ONDAX SCIENTIFIC: OPERATING SEGMENTS
TABLE 101.ONDAX SCIENTIFIC: SERVICE PORTFOLIO
TABLE 102.TRIVERITAS: COMPANY SNAPSHOT
TABLE 103.TRIVERITAS: OPERATING SEGMENTS
TABLE 104.TRIVERITAS: SERVICE PORTFOLIO
TABLE 105.VRM: COMPANY SNAPSHOT
TABLE 106.VRM: OPERATING SEGMENTS
TABLE 107.VRM: SERVICE PORTFOLIO
TABLE 108.VETPHARM, INC.: COMPANY SNAPSHOT
TABLE 109.VETPHARM, INC.: BUSINESS SEGMENTS
TABLE 110.VETPHARM, INC.: SERVICE PORTFOLIO
TABLE 111.VETSPIN SRL.: COMPANY SNAPSHOT
TABLE 112.VETSPIN SRL.: OPERATING SEGMENTS
TABLE 113.VETSPIN SRL: SERVICE PORTFOLIO
LIST OF FIGURES
FIGURE 01.VETERINARY CRO MARKET: SEGMENTATION
FIGURE 02.TOP IMPACTING FACTORS
FIGURE 03.TOP INVESTMENT POCKETS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 06.LOW THREAT OF NEW ENTRANTS
FIGURE 08.HIGH COMPETITIVE RIVALRY
FIGURE 09.TOP PLAYER POSITIONING, 2020
FIGURE 10.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2021–2030
FIGURE 11.TOP WINNING STRATEGIES:BY DEVELOPMENT, 2021–2030
FIGURE 12.TOP WINNING STRATEGIES: BY COMPANY, 2021-2030 (%)
FIGURE 13.U.S. PET INDUSTRY EXPENDITURE, 2014–2021($BILLION)
FIGURE 14.IMPACT ANALYSES
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CLINICAL TRIALS, BY COUNTRY, 2020 & 2030(%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR TOXICOLOGY SERVICE, BY COUNTRY, 2020 & 2030(%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR MARKET AUTHORIZATION AND REGULATORY SUPPORT SERVICE, BY COUNTRY, 2020 & 2030(%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER SERVICES, BY COUNTRY, 2020 & 2030(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR DOGS, BY COUNTRY, 2020 & 2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR CATS, BY COUNTRY, 2020 & 2030(%)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR DERMATOLOGY, BY COUNTRY, 2020 & 2030(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR GASTROINTESTINAL, BY COUNTRY, 2020 & 2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF VETERINARY CRO MARKET FOR OTHER INDICATIONS, BY COUNTRY, 2020 & 2030(%)
FIGURE 24.U.S. VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 25.CANADA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 26.MEXICO VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 27.GERMANY VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 28.FRANCE VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 29.UK VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 30.ITALY VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 31.SPAIN VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 32.REST OF EUROPE VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 33.JAPAN VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 34.CHINA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 35.AUSTRALIA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 36.REST OF ASIA-PACIFIC VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 37.BRAZIL VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 38.SAUDI ARABIA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 39.SOUTH AFRICA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 40.REST OF LAMEA VETERINARY CRO MARKET, 2020-2030 ($MILLION)
FIGURE 41.CHARLES RIVER LABORATORIES INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 43.CHARLES RIVER LABORATORIES INC.: REVENUE SHARE, BY REGION, 2020 (%)
Veterinary CROs are organizations that offer support to veterinary drug manufacturers in the form of services. For instance, clinical trials involve handling large number of animals, which require specially designed facilities; therefore, veterinary CROs manage clinical trials for companies, which are engaged in the introduction of new veterinary medications.
Factor such as owing to increase in pet ownership across the globe. In addition, the market is exhibiting high growth rate, owing to surge in awareness about animal healthcare among owners. Moreover, surge in prevalence of various diseases such as cancer and infectious diseases among companion animals lead to serious deterioration of animal health, which can also cause death. This drives the growth of the market. These factors are expected to facilitate R&D in veterinary medicine, in turn leading to outsource of these services to veterinary CROs. Likewise, various newer technologies from diagnostics are being adapted for the veterinary domain. This tendency is projected to continue in the future, which contributes toward the growth of the veterinary CRO market.
In addition, North America is expected to offer remunerative growth opportunities to key players operating in the industry. This is majorly attributed to factors such as development in animal healthcare facilities and rise in disposable income. Growth in awareness in emerging economies about animal health and the need to prevent infectious diseases are key opportunities for the veterinary CRO market.
A. Major players operating in the market include Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd, VetPharm, Inc., and VETSPIN SRL
A. The total market value of Veterinary CRO Market is $1,175.72 Million in 2030
A. The forecast period in the report is from 2021 to 2030
A. The market value of Veterinary CRO in 2020 was 577.20 million in 2020
A. The base year for the report is 2020
A. Yes, Veterinary CRO Market companies are profiled in the report
A. The top companies that hold the market share in Veterinary CRO Market are Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Löhlein & Wolf Vet Research, Oncovet Clinical Research
A. No, there is no value chain analysis provided in the Veterinary CRO Market report
A. The key trends in the Veterinary CRO Market areincrease in companion animal ownership, an increase in animal health expenditure are the key factors driving the market growth.t
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report